| 摘要 |
<p>The invention relates to fibrin-specific single-chain antibodies, thrombolytic agents derived from such antibodies, and DNA fragments coding for such polypeptides. The single-chain antibodies can be used for imaging, while the thrombolytic agents can be used for in vivo lysis of thrombi.</p> |
